The Pandemic Impact: Focusing on Security of Supply in Pharma
April 28, 2022
Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?
1 min read

April 28, 2022
Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?
1 min read
April 28, 2022
Quality Assured: How PCI Pharma Services helps to bring life- changing therapies to patients
1 min read
April 28, 2022
More and more researchers are exploring the exciting potential of mRNA, most often in combination with encapsulation into lipid nanoparticles. For this, they require lab-scale systems that support their R&D efforts. To address this need, KNAUER has developed the IJM NanoScaler for lab-scale lipid nanoparticle production
1 min read
April 27, 2022
What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research
1 min read
April 26, 2022
How could the spotlight on mRNA impact the cell and gene field?
1 min read
April 25, 2022
What will drug development look like aboard a new commercial space station?
1 min read
April 21, 2022
Advanced analytical technologies now offer the detailed assessments of structure and function that developers need to bring their molecules to market
1 min read
April 20, 2022
Rare diseases do not readily grab the attention of the pharma industry, but more companies are beginning to take notice. As interest slowly grows, what considerations must be made?
1 min read
April 19, 2022
How multi-column chromatography can support companies as they set their sights on intensified bioprocesses
1 min read
April 19, 2022
How should companies build resilient supply chains?
1 min read
False
False